Skip to main content

UCL Technology Fund and Orchard Therapeutics: from idea to Nasdaq IPO and beyond

UCL Technology Fund and Orchard Therapeutics: from idea to Nasdaq IPO and beyond

Dr Simon Goldman, interviews CEO of Orchard Therapeutics, Professor Bobby Gaspar.